The short version of purity testing fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-05-05. Anything still debated is marked as such rather than presented as settled.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
As of 28 October, the number of US troops in the Southern Caribbean and Puerto Rico had expanded to 10,000, with about half in Puerto Rico and half on vessels. US military assets in the region are insufficient for an invasion. The forces included elements of the 160th Special Operations Aviation Regiment which provides helicopter aviation support for special operations forces. Venezuela's armed forces are estimated at 125,000 as of October 2025, with experts saying its military is "in shambles" according to The Wall Street Journal, which wrote on 17 October that Venezuela had issued a call to arms, and "cranked up its propaganda machine", announcing that the US wanted its oil wealth, as Venezuela was moving troops to the coast and prepared to "repel any invasion". With the 11 November arrival of USS Gerald R. Ford and its escorts to the USSOUTHCOM region, the US had about 15,000 personnel in the area, described by The Washington Post as "a stunning military presence in a region that historically has seen only one or two Navy vessels assisting the U.S. Coast Guard on routine drug-interdiction missions". Reuters reported on 2 November 2025 that: "The military buildup in the region is the largest unrelated to disaster relief since 1994, when the United States sent two aircraft carriers and more than 20,000 troops to Haiti" during Operation Uphold Democracy.
Trisomy 13 and 18 Analysis of cffDNA from maternal plasma with MPSS looking for trisomy 13 or 18 is possible Factors limiting sensitivity and specificity include the levels of cffDNA in the maternal plasma; maternal chromosomes may have mosaicism. A number of fetal nucleic acid molecules derived from aneuploid chromosomes can be detected including SERPINEB2 mRNA, clad B, hypomethylated SERPINB5 from chromosome 18, placenta-specific 4 (PLAC4), hypermethylated holocarboxylase synthetase (HLCS) and c21orf105 mRNA from chromosome 12. With complete trisomy, the mRNA alleles in maternal plasma isn't the normal 1:1 ratio, but is in fact 2:1. Allelic ratios determined by epigenetic markers can also be used to detect the complete trisomies. Massive parallel sequencing and digital PCR for fetal aneuploidy detection can be used without restriction to fetal-specific nucleic acid molecules. (MPSS) is estimated to have a sensitivity of between 96 and 100%, and a specificity between 94 and 100% for detecting Down syndrome. It can be performed at 10 weeks of gestational age. One study in the United States estimated a false positive rate of 0.3% and a positive predictive value of 80% when using cffDNA to detect Down syndrome.
=== South American think tanks === Research done by Enrique Mendizabal shows that South American think tanks play various roles depending on their origins, historical development and relations to other policy actors. In this study, Orazio Bellettini from Grupo FARO suggests that they:
=== Illegal drug trafficking === Drug trafficking sales have gone up in Colombia since the 1970s due to the conflict. Many Mexican drug cartels have been spotted operating in the area, including the Sinaloa Cartel, Gulf Cartel, Beltrán Leyva Cartel, CJNG, and Los Zetas. The Medellín Cartel and Cali Cartel were the first drug trafficking organizations in Colombia and had alliances with the Guadalajara Cartel, Los Valencia Organization, and Amezcua Cartel.
=== Encounters with humans === Attacks on humans are rare, but Komodo dragons have been responsible for several human fatalities, both in the wild and in captivity. According to data from Komodo National Park spanning a 38-year period between 1974 and 2012, there were 24 reported attacks on humans, five of them fatal. Most of the victims were local villagers living around the national park. Komodo dragons generally avoid encounters with humans. Juveniles are very shy and will flee quickly into a hideout if a human comes closer than about 100 metres (330 ft). Older animals will also retreat from humans from a shorter distance away. If cornered, they may react aggressively by gaping their mouth, hissing, and swinging their tail. If they are disturbed further, they may attack and bite. Although there are anecdotes of unprovoked Komodo dragons attacking or preying on humans, most of these reports are either not reputable or have subsequently been interpreted as defensive bites. Only very few cases are truly the result of unprovoked attacks by atypical individuals who lost their fear of humans.
Sources: en.wikipedia.org
Conrad Elvehjem, the son of Norwegian emigrants to Wisconsin, was born in McFarland, Wisconsin. He progressed through the secondary schools and the University of Wisconsin, where he received his PhD in 1927 with mentor E.B. Hart for his studies of the importance of copper in iron-deficiency anemia. A National Research Council fellowship permitted a year at Cambridge University in England. Elvehjem began teaching in agricultural chemistry at the University of Wisconsin in 1923, and became a full professor in 1936. He became chairman of the biochemistry department in 1944 and dean of the graduate school in 1946, at 45 years of age. He served as dean of the graduate school until he became the university's 13th president in 1958. Picking up on the work of Joseph Goldberger, he found that nicotinic acid cured black tongue in dogs, an analogous disease to pellagra. In the previous year, Elvehjem and his colleague Carl J. Koehn had found that a filtrate factor from a liver extract could cure diet-induced pellagra in chicks. That filtrate extract was designated as the vitamin G fraction, after the late Goldberger. To confirm their findings in dogs, they induced black tongue in these animals with the Goldberger diet of yellow corn, before supplementing the diet with the vitamin G fraction. Elvehjem and his colleagues later were able to isolate and identify nicotinamide and nicotinic acid from vitamin G as the curative factors for black tongue in dogs.
This provided ammunition to a nationalistic and antisemitic communist party faction headed by Mieczysław Moczar that was opposed to Gomułka's leadership. Using the context of the military victory of Israel in the Six-Day War of 1967, some in the Polish communist leadership waged an antisemitic campaign against the remnants of the Jewish community in Poland. The targets of this campaign were accused of disloyalty and active sympathy with Israeli aggression. Branded "Zionists", they were scapegoated and blamed for the unrest in March 1968, which eventually led to the emigration of much of Poland's remaining Jewish population (about 15,000 Polish citizens left the country). With the active support of the Gomułka regime, the Polish People's Army took part in the infamous Warsaw Pact invasion of Czechoslovakia in August 1968, after the Brezhnev Doctrine was informally announced. In the final major achievement of Gomułka diplomacy, the governments of Poland and West Germany signed in December 1970 the Treaty of Warsaw, which normalized their relations and made possible meaningful cooperation in a number of areas of bilateral interest. In particular, West Germany recognized the post-World War II de facto border between Poland and East Germany.
== See also == All pages with titles containing Link Linc (disambiguation) Lincs (disambiguation) Linker (disambiguation) Linq (disambiguation) Linx (disambiguation) Lynx (disambiguation) Microsoft Lync Linkt, road tolling brand in Australia
The team discovered that Penicillium extract killed several types of bacteria. Gardner and Orr-Ewing tested it against gonococci (against which it was most effective), meningococci, streptococci, staphylococci, anthrax bacteria, Actinomyces and the organisms that caused tetanus and gangrene. Florey and Jennings experimented on rats, mice, rabbits and cats in which penicillin was administered in various ways, and found no evidence of toxicity. On 25 May 1940, Florey injected eight mice with a virulent strain of streptococcus, and then four of them with penicillin. A day later all four of the untreated mice were dead, but all of the treated ones were still alive, although one died two days later. Over the following weeks Jennings and Florey repeated the experiment with ever-larger batches of mice, and with different bacteria. They found that penicillin was also effective against staphylococci and the bacteria that cause gangrene. They published their findings in The Lancet on 24 August 1940. Florey reminded his staff that as promising as their results were, a man weighed 3,000 times as much as a mouse. In February 1941, Florey and Chain treated their first patient, Albert Alexander, who had had a small sore at the corner of his mouth, which then spread, leading to a severe facial infection involving streptococci and staphylococci. His whole face, eyes and scalp were swollen to the extent that he had had an eye removed to relieve the pain. Within a day of being given penicillin, he started to recover.
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.